To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
BioStar wraps up fifth fund at $130.3m
BioStar Capital is focused on medical technologies primarily in the fields of cardiovascular disease, orthopedics, and robotics.
